Australian Clinical Labs Limited (ASX:ACL)

Australia · Delayed Price · Currency is AUD

2.215

+0.025 (1.14%)

Feb 26, 2026, 3:59 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Pathology/Clinical Laboratory Services	741.27M	696.37M	697.07M	995.60M	646.70M
Pathology/Clinical Laboratory Services Growth	6.45%	-0.10%	-29.99%	53.95%	31.83%
Total	741.27M	696.37M	697.07M	995.60M	646.70M
Total Growth	6.45%	-0.10%	-29.99%	53.95%	31.83%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia	741.27M	696.37M	697.07M	995.60M	646.70M
Australia Growth	6.45%	-0.10%	-29.99%	53.95%	31.83%
Total	741.27M	696.37M	697.07M	995.60M	646.70M
Total Growth	6.45%	-0.10%	-29.99%	53.95%	31.83%

Source: S&P Global Market Intelligence.